INS and fatty liver disease: As previously mentioned, KuA is a major bioactive component extracted from the root barks of LC which can upregulate Srebp-1c and inhibit insulin-stimulated glucose uptake and lipid accumulation in hepatic steatosis (Li et al. 2017).